| Sr No. |
|
Additional disclosure of related
party transactions - applicable only in case the related party transaction relates to loans,
inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary.
These details need to be disclosed only once, during the reporting period when such transaction was
undertaken. |
| Details of the party (listed entity/subsidiary) entering into the transaction |
Details of the counterparty |
Type of related party transaction |
Details of other related party transaction |
Value of the related party transaction as approved by the audit committee |
Remarks on approval by audit committee |
Value of the related party transaction ratified by the audit committee |
Date of Audit Committee Meeting where the ratification was approved |
Value of transaction during the reporting period |
In case monies are due to either party as a result of the transaction |
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments |
Details of the loans, inter-corporate deposits, advances or investments |
Notes |
| Name |
PAN |
Name |
PAN |
Relationship of the counterparty with the listed entity or its subsidiary |
Opening balance |
Closing balance |
Nature of indebtedness (loan/ issuance of debt/ any other etc.) |
Details of other indebtedness |
Cost |
Tenure |
Nature (loan/ advance/ intercorporate deposit/ investment ) |
Interest Rate (%) |
Tenure |
Secured/ unsecured |
Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
| 1 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Advance |
|
|
- |
|
|
0.00 |
4,800.00 |
4,800.00 |
|
|
|
|
|
|
|
|
|
|
| 2 |
Lupin Limited |
|
Shubanprint Pack Pvt. Ltd. |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Advance |
|
|
- |
|
|
0.00 |
148.30 |
148.30 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
90.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 4 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
54.70 |
76.90 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
193.00 |
575.10 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Lupin Limited |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
60.30 |
307.50 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
253.10 |
291.00 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
13.50 |
32.90 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
9.00 |
10.60 |
|
|
|
|
|
|
|
|
|
|
| 10 |
Lupin Limited |
|
Lupin Europe GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
480.80 |
1,517.20 |
|
|
|
|
|
|
|
|
|
|
| 11 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
2,266.60 |
2,787.70 |
|
|
|
|
|
|
|
|
|
|
| 12 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
3,782.70 |
4,494.40 |
|
|
|
|
|
|
|
|
|
|
| 13 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
3.70 |
3.10 |
|
|
|
|
|
|
|
|
|
|
| 14 |
Lupin Limited |
|
Lupin Management, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
5,710.00 |
4,547.90 |
|
|
|
|
|
|
|
|
|
|
| 15 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
10,317.60 |
13,788.10 |
|
|
|
|
|
|
|
|
|
|
| 16 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
12.90 |
5.30 |
|
|
|
|
|
|
|
|
|
|
| 17 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
571.00 |
603.80 |
|
|
|
|
|
|
|
|
|
|
| 18 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
23,135.20 |
5,516.00 |
|
|
|
|
|
|
|
|
|
|
| 19 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
7,781.40 |
8,875.30 |
|
|
|
|
|
|
|
|
|
|
| 20 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
2.10 |
2.10 |
|
|
|
|
|
|
|
|
|
|
| 21 |
Lupin Limited |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
85.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 22 |
Lupin Limited |
|
Novel Laboratories, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
84.00 |
1,105.60 |
|
|
|
|
|
|
|
|
|
|
| 23 |
Lupin Limited |
|
S. N. Pharma |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
0.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 24 |
Lupin Limited |
|
Shubanprint Pack Pvt. Ltd. |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
43.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 25 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
4,617.70 |
6,937.60 |
|
|
|
|
|
|
|
|
|
|
| 26 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
6,774.90 |
3,438.80 |
|
|
|
|
|
|
|
|
|
|
| 27 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
5,772.30 |
4,454.10 |
|
|
|
|
|
|
|
|
|
|
| 28 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
22,044.20 |
20,752.20 |
|
|
|
|
|
|
|
|
|
|
| 29 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
82,620.90 |
38,732.80 |
|
|
|
|
|
|
|
|
|
|
| 30 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
52.10 |
40.70 |
|
|
|
|
|
|
|
|
|
|
| 31 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
118.60 |
136.90 |
|
|
|
|
|
|
|
|
|
|
| 32 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
(226.90) |
42.20 |
|
|
|
|
|
|
|
|
|
|
| 33 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
4,573.90 |
7,590.30 |
|
|
|
|
|
|
|
|
|
|
| 34 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
4,39,526.40 |
4,96,338.50 |
|
|
|
|
|
|
|
|
|
|
| 35 |
Lupin Limited |
|
Lupin Philippines, Inc., Philippines |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
7,480.10 |
5,224.30 |
|
|
|
|
|
|
|
|
|
|
| 36 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
51.60 |
157.10 |
|
|
|
|
|
|
|
|
|
|
| 37 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
16.20 |
1.60 |
|
|
|
|
|
|
|
|
|
|
| 38 |
Lupin Limited |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Wholly -Owned Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
6,781.00 |
2,463.90 |
|
|
|
|
|
|
|
|
|
|
| 39 |
Lupin Limited |
|
Zyma Properties Pvt. Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Inter-corporate deposit |
|
|
- |
|
|
0.00 |
74.00 |
74.00 |
|
|
|
|
|
|
|
|
|
|
| 40 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Deposits received balance Premises |
|
- |
|
|
0.00 |
30.00 |
30.00 |
|
|
|
|
|
|
|
|
|
|
| 41 |
Lupin Limited |
|
Polynova Industries Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Deposits received balance Premises |
|
- |
|
|
0.00 |
1.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 42 |
Lupin Limited |
|
Polynova Industries Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
100.00 |
Approved |
|
|
1.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 43 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
25.20 |
74.70 |
|
|
|
|
|
|
|
|
|
|
| 44 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
39.00 |
163.10 |
|
|
|
|
|
|
|
|
|
|
| 45 |
Lupin Limited |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
62.10 |
405.20 |
|
|
|
|
|
|
|
|
|
|
| 46 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
116.30 |
342.40 |
|
|
|
|
|
|
|
|
|
|
| 47 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
138.10 |
3.80 |
|
|
|
|
|
|
|
|
|
|
| 48 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
61.10 |
3.20 |
|
|
|
|
|
|
|
|
|
|
| 49 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
33.20 |
196.30 |
|
|
|
|
|
|
|
|
|
|
| 50 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
50.60 |
2,699.60 |
|
|
|
|
|
|
|
|
|
|
| 51 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
0.60 |
10.30 |
|
|
|
|
|
|
|
|
|
|
| 52 |
Lupin Limited |
|
Lupin Management, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
493.70 |
1,959.30 |
|
|
|
|
|
|
|
|
|
|
| 53 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
117.80 |
343.50 |
|
|
|
|
|
|
|
|
|
|
| 54 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
0.00 |
5.10 |
|
|
|
|
|
|
|
|
|
|
| 55 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
16.30 |
90.20 |
|
|
|
|
|
|
|
|
|
|
| 56 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
140.90 |
864.30 |
|
|
|
|
|
|
|
|
|
|
| 57 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
133.80 |
175.20 |
|
|
|
|
|
|
|
|
|
|
| 58 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
2.50 |
10.50 |
|
|
|
|
|
|
|
|
|
|
| 59 |
Lupin Limited |
|
Medisol S.A.S., France |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
0.00 |
67.90 |
|
|
|
|
|
|
|
|
|
|
| 60 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
27.80 |
33.70 |
|
|
|
|
|
|
|
|
|
|
| 61 |
Lupin Limited |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
21.70 |
49.10 |
|
|
|
|
|
|
|
|
|
|
| 62 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
126.40 |
113.80 |
|
|
|
|
|
|
|
|
|
|
| 63 |
Lupin Limited |
|
Novel Laboratories, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
56.90 |
123.00 |
|
|
|
|
|
|
|
|
|
|
| 64 |
Lupin Limited |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
22.50 |
90.20 |
|
|
|
|
|
|
|
|
|
|
| 65 |
Lupin Limited |
|
TeamLease Services Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Expenses receivable |
|
- |
|
|
0.00 |
0.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 66 |
Lupin Limited |
|
Lupin Australia Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Payable |
|
- |
|
|
0.00 |
279.90 |
548.30 |
|
|
|
|
|
|
|
|
|
|
| 67 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
25.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 68 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
207.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 69 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
18.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 70 |
Lupin Limited |
|
Lupin Australia Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
549.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 71 |
Lupin Limited |
|
Lupin Europe GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
1,491.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 72 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
532.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 73 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
63.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 74 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
22.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 75 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
307.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 76 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
4,349.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 77 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses Reimbursed |
|
- |
|
|
1.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 78 |
Lupin Limited |
|
Shubanprint Pack Pvt. Ltd. |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Expenses Reimbursed |
100.00 |
Approved |
|
|
8.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 79 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Guarantee Fees Income |
1,000.00 |
Approved |
|
|
307.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 80 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Any other transaction |
Guarantee Fees Income |
300.00 |
Approved |
|
|
93.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 81 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Any other transaction |
Guarantee Fees Income |
700.00 |
Approved |
|
|
234.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 82 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
42.90 |
46.50 |
|
|
|
|
|
|
|
|
|
|
| 83 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
13.70 |
14.40 |
|
|
|
|
|
|
|
|
|
|
| 84 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
539.50 |
818.60 |
|
|
|
|
|
|
|
|
|
|
| 85 |
Lupin Limited |
|
Lupin Australia Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
1.50 |
1.20 |
|
|
|
|
|
|
|
|
|
|
| 86 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
61.70 |
140.90 |
|
|
|
|
|
|
|
|
|
|
| 87 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
9.20 |
15.30 |
|
|
|
|
|
|
|
|
|
|
| 88 |
Lupin Limited |
|
Lupin Europe GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
2.50 |
2.50 |
|
|
|
|
|
|
|
|
|
|
| 89 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
12.00 |
13.10 |
|
|
|
|
|
|
|
|
|
|
| 90 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
1,472.20 |
456.50 |
|
|
|
|
|
|
|
|
|
|
| 91 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
650.30 |
454.60 |
|
|
|
|
|
|
|
|
|
|
| 92 |
Lupin Limited |
|
Lupin Management, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
10.90 |
12.10 |
|
|
|
|
|
|
|
|
|
|
| 93 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
2,531.70 |
524.10 |
|
|
|
|
|
|
|
|
|
|
| 94 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
1.40 |
0.80 |
|
|
|
|
|
|
|
|
|
|
| 95 |
Lupin Limited |
|
Lupin Oncology Inc., USA |
|
Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
2,525.00 |
3,838.30 |
|
|
|
|
|
|
|
|
|
|
| 96 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
26.50 |
35.40 |
|
|
|
|
|
|
|
|
|
|
| 97 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
321.90 |
250.30 |
|
|
|
|
|
|
|
|
|
|
| 98 |
Lupin Limited |
|
Lupin Philippines, Inc., Philippines |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
5.00 |
2.30 |
|
|
|
|
|
|
|
|
|
|
| 99 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
22.40 |
22.60 |
|
|
|
|
|
|
|
|
|
|
| 100 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
10.20 |
186.30 |
|
|
|
|
|
|
|
|
|
|
| 101 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
45.00 |
46.90 |
|
|
|
|
|
|
|
|
|
|
| 102 |
Lupin Limited |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
16.80 |
13.70 |
|
|
|
|
|
|
|
|
|
|
| 103 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
493.30 |
916.20 |
|
|
|
|
|
|
|
|
|
|
| 104 |
Lupin Limited |
|
Novel Laboratories, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
20.00 |
19.80 |
|
|
|
|
|
|
|
|
|
|
| 105 |
Lupin Limited |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
23.30 |
27.70 |
|
|
|
|
|
|
|
|
|
|
| 106 |
Lupin Limited |
|
Southern Cross Pharma Pty Ltd., Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
3.00 |
2.10 |
|
|
|
|
|
|
|
|
|
|
| 107 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Interest received |
|
|
- |
|
|
88.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 108 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Interest received |
|
|
- |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 109 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Interest received |
|
|
- |
|
|
467.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 110 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Interest received |
|
|
- |
|
|
164.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 111 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
2,490.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 112 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
28,438.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 113 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
2,53,800.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 114 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
3,28,055.60 |
3,28,055.60 |
|
|
|
|
|
|
|
|
|
|
| 115 |
Lupin Limited |
|
Lupin Australia Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
333.20 |
333.20 |
|
|
|
|
|
|
|
|
|
|
| 116 |
Lupin Limited |
|
Lupin Biologics Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
15.00 |
15.00 |
|
|
|
|
|
|
|
|
|
|
| 117 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
43,816.60 |
43,816.60 |
|
|
|
|
|
|
|
|
|
|
| 118 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
25,000.00 |
27,490.00 |
|
|
|
|
|
|
|
|
|
|
| 119 |
Lupin Limited |
|
Lupin Lanka (Private) Ltd., Sri Lanka |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
167.50 |
167.50 |
|
|
|
|
|
|
|
|
|
|
| 120 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2,510.00 |
2,510.00 |
|
|
|
|
|
|
|
|
|
|
| 121 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,14,450.00 |
1,42,888.50 |
|
|
|
|
|
|
|
|
|
|
| 122 |
Lupin Limited |
|
Lupin Oncology Inc., USA |
|
Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
11,278.50 |
11,278.50 |
|
|
|
|
|
|
|
|
|
|
| 123 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
137.90 |
137.90 |
|
|
|
|
|
|
|
|
|
|
| 124 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
90,010.00 |
90,010.00 |
|
|
|
|
|
|
|
|
|
|
| 125 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
6,12,654.50 |
8,66,454.80 |
|
|
|
|
|
|
|
|
|
|
| 126 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
5,000.00 |
|
|
|
|
Loan |
7.0500 |
1 year |
Unsecured |
Business Purpose |
|
| 127 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
12,500.00 |
11,500.00 |
|
|
|
|
Loan |
8.00 |
5 years |
Unsecured |
Business Purpose |
|
| 128 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
10,000.00 |
0.00 |
|
|
|
|
Loan |
7.0500 |
1 year |
Unsecured |
Business Purpose |
|
| 129 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
5,000.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
7.0500 |
1 year |
Unsecured |
Business Purpose |
|
| 130 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
150.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
7.0500 |
3 months |
Unsecured |
Business Purpose |
|
| 131 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
150.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
7.0500 |
3 months |
Unsecured |
Business Purpose |
Textual Information(1) |
| 132 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
1,000.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
8.00 |
5 years |
Unsecured |
Business Purpose |
Textual Information(2) |
| 133 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Loan |
|
|
- |
|
|
10,000.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
7.0500 |
1 year |
Unsecured |
Business Purpose |
Textual Information(3) |
| 134 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Product Development Expense |
9,500.00 |
Approved |
|
|
7,624.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 135 |
Lupin Limited |
|
Novel Laboratories, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Product Development Expense |
840.00 |
Approved |
|
|
753.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 136 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
3,000.00 |
Approved |
|
|
635.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 137 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
63,400.00 |
Approved |
|
|
19,840.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 138 |
Lupin Limited |
|
Shubanprint Pack Pvt. Ltd. |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Purchase of goods or services |
|
2,100.00 |
Approved |
|
|
844.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 139 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
110.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 140 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
248.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 141 |
Lupin Limited |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
440.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 142 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
434.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 143 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
59.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 144 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
33.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 145 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
232.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 146 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
2,699.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 147 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
51.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 148 |
Lupin Limited |
|
Lupin Management, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
2,844.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 149 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
364.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 150 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
6.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 151 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
105.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 152 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
1,357.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 153 |
Lupin Limited |
|
Lupin Philippines, Inc., Philippines |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 154 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
187.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 155 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
18.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 156 |
Lupin Limited |
|
Medisol S.A.S., France |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
68.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 157 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
62.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 158 |
Lupin Limited |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
200.00 |
Approved |
|
|
66.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 159 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
105.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 160 |
Lupin Limited |
|
Novel Laboratories, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
161.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 161 |
Lupin Limited |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Wholly -Owned Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
103.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 162 |
Lupin Limited |
|
Polynova Industries Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Expenses incurred on their behalf recovered |
100.00 |
Approved |
|
|
0.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 163 |
Lupin Limited |
|
Mr. Nilesh D. Gupta |
|
Key Management Personnel |
Remuneration |
|
2,000.00 |
Approved |
|
|
1,552.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 164 |
Lupin Limited |
|
Mrs. Manju D. Gupta |
|
Non- Executive Directors |
Remuneration |
|
90.00 |
Approved |
|
|
29.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 165 |
Lupin Limited |
|
Ms.Vinita Gupta |
|
Key Management Personnel |
Remuneration |
|
3,610.00 |
Approved |
|
|
2,566.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 166 |
Lupin Limited |
|
Zyma Properties Pvt. Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Rent expense |
200.00 |
Approved |
|
|
62.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 167 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Rent Income |
100.00 |
Approved |
|
|
11.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 168 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Rent Income |
1,520.00 |
Approved |
|
|
706.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 169 |
Lupin Limited |
|
Polynova Industries Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Any other transaction |
Rent Income |
30.00 |
Approved |
|
|
8.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 170 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
40.00 |
Approved |
|
|
25.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 171 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
11.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 172 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
2,300.00 |
Approved |
|
|
1,091.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 173 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
5,400.00 |
Approved |
|
|
746.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 174 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
3,300.00 |
Approved |
|
|
221.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 175 |
Lupin Limited |
|
Lupin Oncology Inc., USA |
|
Subsidiary |
Sale of goods or services |
|
5,200.00 |
Approved |
|
|
1,280.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 176 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
5.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 177 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
800.00 |
Approved |
|
|
172.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 178 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
20,600.00 |
Approved |
|
|
8,264.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 179 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
13,800.00 |
Approved |
|
|
5,190.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 180 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
21,800.00 |
Approved |
|
|
5,199.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 181 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
0.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 182 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
45,400.00 |
Approved |
|
|
20,847.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 183 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
2,36,800.00 |
Approved |
|
|
62,108.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 184 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
220.00 |
Approved |
|
|
59.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 185 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
1,600.00 |
Approved |
|
|
89.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 186 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
1,100.00 |
Approved |
|
|
128.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 187 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
25,700.00 |
Approved |
|
|
7,692.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 188 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
8,99,500.00 |
Approved |
|
|
3,36,043.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 189 |
Lupin Limited |
|
Lupin Philippines, Inc., Philippines |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
2,400.00 |
Approved |
|
|
1,570.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 190 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
400.00 |
Approved |
|
|
189.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 191 |
Lupin Limited |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Subsidiary |
Sale of goods or services |
|
600.00 |
Approved |
|
|
181.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 192 |
Lupin Limited |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
20,900.00 |
Approved |
|
|
7,103.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 193 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
1,050.00 |
Approved |
|
|
404.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 194 |
Lupin Limited |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
400.00 |
Approved |
|
|
319.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 195 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
750.00 |
Approved |
|
|
270.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 196 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
240.00 |
Approved |
|
|
90.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 197 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
20.00 |
Approved |
|
|
7.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 198 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
3,400.00 |
Approved |
|
|
1,023.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 199 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
2,900.00 |
Approved |
|
|
752.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 200 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
10.00 |
Approved |
|
|
1.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 201 |
Lupin Limited |
|
Lupin Management, Inc., USA |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
10,800.00 |
Approved |
|
|
4,946.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 202 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
100.00 |
Approved |
|
|
27.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 203 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Purchase of goods or services |
|
700.00 |
Approved |
|
|
370.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 204 |
Lupin Limited |
|
Shubanprint Pack Pvt. Ltd. |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Purchase of goods or services |
|
500.00 |
Approved |
|
|
169.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 205 |
Lupin Limited |
|
TeamLease Services Limited |
|
Others (Relatives of KMP and Entities in which the KMP and Relatives of KMP have control or significant influence) |
Purchase of goods or services |
|
1,400.00 |
Approved |
|
|
430.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 206 |
Lupin Limited |
|
Generic Health Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
300.00 |
Approved |
|
|
85.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 207 |
Lupin Limited |
|
Hormosan Pharma GmbH, Germany |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
30.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 208 |
Lupin Limited |
|
Lupin Atlantis Holdings SA, Switzerland |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
70.00 |
Approved |
|
|
19.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 209 |
Lupin Limited |
|
Lupin Australia Pty Limited, Australia |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
10.00 |
Approved |
|
|
2.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 210 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
270.00 |
Approved |
|
|
126.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 211 |
Lupin Limited |
|
Lupin Digital Health Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
30.00 |
Approved |
|
|
6.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 212 |
Lupin Limited |
|
Lupin Europe GmbH, Germany |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
20.00 |
Approved |
|
|
5.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 213 |
Lupin Limited |
|
Lupin Healthcare (UK) Limited, UK |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
25.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 214 |
Lupin Limited |
|
Lupin Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
38.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 215 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
1,270.00 |
Approved |
|
|
253.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 216 |
Lupin Limited |
|
Lupin Management, Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
60.00 |
Approved |
|
|
23.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 217 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
3,050.00 |
Approved |
|
|
1,237.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 218 |
Lupin Limited |
|
Lupin NZ Ltd., New Zealand |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
10.00 |
Approved |
|
|
1.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 219 |
Lupin Limited |
|
Lupin Oncology Inc., USA |
|
Subsidiary |
Sale of goods or services |
|
10.00 |
Approved |
|
|
0.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 220 |
Lupin Limited |
|
Lupin Pharma Canada Limited, Canada |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
200.00 |
Approved |
|
|
60.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 221 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
900.00 |
Approved |
|
|
298.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 222 |
Lupin Limited |
|
Lupin Philippines, Inc., Philippines |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
40.00 |
Approved |
|
|
9.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 223 |
Lupin Limited |
|
Lupin Research Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
150.00 |
Approved |
|
|
43.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 224 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
1,100.00 |
Approved |
|
|
286.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 225 |
Lupin Limited |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
28.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 226 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
50.00 |
Approved |
|
|
16.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 227 |
Lupin Limited |
|
Novel Laboratories, Inc., USA |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
200.00 |
Approved |
|
|
42.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 228 |
Lupin Limited |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
200.00 |
Approved |
|
|
52.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 229 |
Lupin Limited |
|
Southern Cross Pharma Pty Ltd., Australia |
|
Wholly -Owned Subsidiary |
Sale of goods or services |
|
20.00 |
Approved |
|
|
5.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 230 |
Lupin Limited |
|
Lupin Diagnostics Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Corporate guarantees issued by the Company to the bankers of subsidiary company |
|
- |
|
|
0.00 |
5,000.00 |
5,000.00 |
|
|
|
|
|
|
|
|
|
|
| 231 |
Lupin Limited |
|
Lupin Life Sciences Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Corporate guarantees issued by the Company to the bankers of subsidiary company |
|
- |
|
|
0.00 |
500.00 |
500.00 |
|
|
|
|
|
|
|
|
|
|
| 232 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Corporate guarantees issued by the Company to the bankers of subsidiary company |
|
- |
|
|
0.00 |
15,000.00 |
15,000.00 |
|
|
|
|
|
|
|
|
|
|
| 233 |
Lupin Limited |
|
Lupin Pharmaceuticals, Inc., USA |
|
Wholly -Owned Subsidiary |
Any other transaction |
Corporate guarantees issued by the Company to the bankers of subsidiary company |
|
- |
|
|
0.00 |
2,86,804.00 |
2,86,804.00 |
|
|
|
|
|
|
|
|
|
|
| 234 |
Lupin Limited |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Corporate guarantees issued by the Company to the bankers of subsidiary company |
|
- |
|
|
0.00 |
5,000.00 |
5,000.00 |
|
|
|
|
|
|
|
|
|
|
| 235 |
Lupin Limited |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Wholly -Owned Subsidiary |
Any other transaction |
Corporate guarantees issued by the Company to the bankers of subsidiary company |
|
- |
|
|
0.00 |
42,122.00 |
42,122.00 |
|
|
|
|
|
|
|
|
|
|
| 236 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Any other transaction |
Guarantees issued by the Company on behalf of subsidiary companies for contractual obligations |
|
- |
|
|
0.00 |
63,486.00 |
63,486.00 |
|
|
|
|
|
|
|
|
|
|
| 237 |
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Lupin Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Any other transaction |
Rent Income |
|
- |
|
|
2.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 238 |
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Lupin Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
500.00 |
Approved |
|
|
130.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 239 |
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Lupin Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Purchase of goods or services |
|
2,600.00 |
Approved |
|
|
1,465.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 240 |
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Lupin Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
7,777.40 |
866.70 |
|
|
|
|
|
|
|
|
|
|
| 241 |
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Lupin Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
0.70 |
0.60 |
|
|
|
|
|
|
|
|
|
|
| 242 |
Generic Health Pty Limited, Australia |
|
Southern Cross Pharma Pty Ltd., Australia |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
16,659.50 |
16,659.50 |
|
|
|
|
|
|
|
|
|
|
| 243 |
Generic Health Pty Limited, Australia |
|
Lupin Australia Pty Limited, Australia |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
2.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 244 |
Generic Health Pty Limited, Australia |
|
Southern Cross Pharma Pty Ltd., Australia |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
1,403.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 245 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
334.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 246 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
21.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 247 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 248 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
650.40 |
668.40 |
|
|
|
|
Loan |
6.2500 |
3 years |
Unsecured |
Business purpose |
|
| 249 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
253.00 |
253.00 |
|
|
|
|
|
|
|
|
|
|
| 250 |
Generic Health Pty Limited, Australia |
|
Lupin Australia Pty Limited, Australia |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
31.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 251 |
Generic Health Pty Limited, Australia |
|
Lupin Australia Pty Limited, Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivable |
|
- |
|
|
0.00 |
380.80 |
691.70 |
|
|
|
|
|
|
|
|
|
|
| 252 |
Generic Health Pty Limited, Australia |
|
Southern Cross Pharma Pty Ltd., Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Payable |
|
- |
|
|
0.00 |
1,616.80 |
2,314.20 |
|
|
|
|
|
|
|
|
|
|
| 253 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivable |
|
- |
|
|
0.00 |
13.10 |
332.20 |
|
|
|
|
|
|
|
|
|
|
| 254 |
Generic Health Pty Limited, Australia |
|
Southern Cross Pharma Pty Ltd., Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Payable |
|
- |
|
|
0.00 |
49.40 |
494.70 |
|
|
|
|
|
|
|
|
|
|
| 255 |
Generic Health Pty Limited, Australia |
|
Lupin Australia Pty Limited, Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Payable |
|
- |
|
|
0.00 |
2.20 |
32.00 |
|
|
|
|
|
|
|
|
|
|
| 256 |
Generic Health Pty Limited, Australia |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
1.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 257 |
Lupin Australia Pty Limited, Australia |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivable |
|
- |
|
|
0.00 |
16.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 258 |
Lupin Manufacturing Solutions Limited, India |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,978.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 259 |
Lupin Manufacturing Solutions Limited, India |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
1,850.70 |
5,084.20 |
|
|
|
|
|
|
|
|
|
|
| 260 |
Lupin Manufacturing Solutions Limited, India |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
729.70 |
326.20 |
|
|
|
|
|
|
|
|
|
|
| 261 |
Lupin Manufacturing Solutions Limited, India |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
170.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 262 |
Lupin Manufacturing Solutions Limited, India |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
7.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 263 |
Lupin Healthcare (UK) Limited, UK |
|
Renascience Pharma Limited, UK |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
241.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 264 |
Lupin Healthcare (UK) Limited, UK |
|
Renascience Pharma Limited, UK |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
611.90 |
241.50 |
|
|
|
|
|
|
|
|
|
|
| 265 |
Lupin Pharma Canada Limited, Canada |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
0.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 266 |
Lupin Pharma Canada Limited, Canada |
|
Lupin NZ Ltd., New Zealand |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
7.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 267 |
Lupin Pharma Canada Limited, Canada |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.20 |
0.50 |
|
|
|
|
|
|
|
|
|
|
| 268 |
Lupin Inc., USA |
|
Generic Health Pty Limited, Australia |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
148.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 269 |
Lupin Inc., USA |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
52.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 270 |
Lupin Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
266.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 271 |
Lupin Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
804.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 272 |
Lupin Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
39.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 273 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
100.00 |
Approved |
|
|
9.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 274 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
100.00 |
Approved |
|
|
11.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 275 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
623.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 276 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
62.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 277 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
162.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 278 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
3.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 279 |
Lupin Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1,18,607.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 280 |
Lupin Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
587.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 281 |
Lupin Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
657.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 282 |
Lupin Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
53.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 283 |
Lupin Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
1,101.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 284 |
Lupin Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
573.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 285 |
Lupin Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
89.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 286 |
Lupin Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
82.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 287 |
Medisol S.A.S., France |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
8.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 288 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
23.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 289 |
Lupin Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
43,696.10 |
44,801.60 |
|
|
|
|
|
|
|
|
|
|
| 290 |
Lupin Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
98,324.10 |
1,05,760.40 |
|
|
|
|
|
|
|
|
|
|
| 291 |
Lupin Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
2,302.70 |
579.40 |
|
|
|
|
|
|
|
|
|
|
| 292 |
Lupin Inc., USA |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
3.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 293 |
Lupin Inc., USA |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.00 |
8.40 |
|
|
|
|
|
|
|
|
|
|
| 294 |
Lupin Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
19,559.10 |
17,934.10 |
|
|
|
|
|
|
|
|
|
|
| 295 |
Lupin Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
11,499.40 |
|
|
|
|
Loan |
0 |
1 year |
Unsecured |
Business purpose |
|
| 296 |
Lupin Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
26,705.00 |
28,604.30 |
|
|
|
|
|
|
|
|
|
|
| 297 |
Lupin Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
1,52,313.80 |
1,82,534.30 |
|
|
|
|
|
|
|
|
|
|
| 298 |
Lupin Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
62,364.00 |
77,973.20 |
|
|
|
|
|
|
|
|
|
|
| 299 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
7.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 300 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
209.20 |
665.40 |
|
|
|
|
|
|
|
|
|
|
| 301 |
Lupin Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.00 |
163.50 |
|
|
|
|
|
|
|
|
|
|
| 302 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
15.70 |
21.70 |
|
|
|
|
|
|
|
|
|
|
| 303 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
38,971.60 |
39,489.00 |
|
|
|
|
|
|
|
|
|
|
| 304 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
958.30 |
|
|
|
|
Loan |
4.900 |
2.5 years |
Unsecured |
Business purpose |
|
| 305 |
Lupin Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
47.60 |
|
|
|
|
|
|
|
|
|
|
| 306 |
Lupin Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
35.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 307 |
Lupin Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
45.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 308 |
Lupin Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.00 |
26.70 |
|
|
|
|
|
|
|
|
|
|
| 309 |
Lupin Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
626.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 310 |
Lupin Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
0.00 |
818.40 |
|
|
|
|
|
|
|
|
|
|
| 311 |
Lupin Inc., USA |
|
Lupin Australia Pty Limited, Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
2.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 312 |
Lupin Management, Inc., USA |
|
Generic Health Pty Limited, Australia |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
59.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 313 |
Lupin Management, Inc., USA |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
153.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 314 |
Lupin Management, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
4,107.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 315 |
Lupin Management, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
2.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 316 |
Lupin Management, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
1.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 317 |
Lupin Management, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
415.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 318 |
Lupin Management, Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
200.00 |
Approved |
|
|
61.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 319 |
Lupin Management, Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
117.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 320 |
Lupin Management, Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
716.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 321 |
Lupin Management, Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
210.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 322 |
Lupin Management, Inc., USA |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
145.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 323 |
Lupin Management, Inc., USA |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Sale of goods or services |
|
200.00 |
Approved |
|
|
88.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 324 |
Nanomi B.V., Netherlands |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
804.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 325 |
Lupin Management, Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
118.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 326 |
Lupin Management, Inc., USA |
|
Lupin Nz Ltd., New Zealand |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
11.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 327 |
Lupin Management, Inc., USA |
|
Generic Health Pty Limited, Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
1.80 |
42.20 |
|
|
|
|
|
|
|
|
|
|
| 328 |
Lupin Management, Inc., USA |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
93.60 |
75.90 |
|
|
|
|
|
|
|
|
|
|
| 329 |
Lupin Management, Inc., USA |
|
Lupin Oncology Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
48.20 |
61.50 |
|
|
|
|
|
|
|
|
|
|
| 330 |
Lupin Management, Inc., USA |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
370.90 |
521.60 |
|
|
|
|
|
|
|
|
|
|
| 331 |
Lupin Management, Inc., USA |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
104.60 |
41.50 |
|
|
|
|
|
|
|
|
|
|
| 332 |
Lupin Management, Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
1,190.80 |
2,014.40 |
|
|
|
|
|
|
|
|
|
|
| 333 |
Lupin Management, Inc., USA |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
26.70 |
27.00 |
|
|
|
|
|
|
|
|
|
|
| 334 |
Lupin Management, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
1,239.50 |
419.00 |
|
|
|
|
|
|
|
|
|
|
| 335 |
Lupin Management, Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
44.80 |
75.30 |
|
|
|
|
|
|
|
|
|
|
| 336 |
Lupin Management, Inc., USA |
|
Lupin Nz Ltd., New Zealand |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
16.80 |
8.40 |
|
|
|
|
|
|
|
|
|
|
| 337 |
Lupin Oncology Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
7,500.00 |
Approved |
|
|
1,521.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 338 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
1,824.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 339 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
531.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 340 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
107.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 341 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
36.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 342 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
467.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 343 |
Nanomi B.V., Netherlands |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,204.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 344 |
Lupin Pharmaceuticals, Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
26.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 345 |
Lupin Pharmaceuticals, Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
209.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 346 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
296.60 |
370.70 |
|
|
|
|
|
|
|
|
|
|
| 347 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
261.80 |
226.00 |
|
|
|
|
|
|
|
|
|
|
| 348 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
754.20 |
228.00 |
|
|
|
|
|
|
|
|
|
|
| 349 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
55.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 350 |
Lupin Pharmaceuticals, Inc., USA |
|
Novel Laboratories, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
21.90 |
145.70 |
|
|
|
|
|
|
|
|
|
|
| 351 |
Lupin Pharmaceuticals, Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
454.00 |
2,180.20 |
|
|
|
|
|
|
|
|
|
|
| 352 |
Lupin Research Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
27,982.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 353 |
Lupin Research Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
141.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 354 |
Lupin Research Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
0.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 355 |
Lupin Research Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
221.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 356 |
Lupin Research Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
60.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 357 |
Nanomi B.V., Netherlands |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
177.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 358 |
Lupin Research Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 359 |
Lupin Research Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
45.80 |
211.70 |
|
|
|
|
|
|
|
|
|
|
| 360 |
Lupin Research Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
0.00 |
0.30 |
|
|
|
|
|
|
|
|
|
|
| 361 |
Lupin Research Inc., USA |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.00 |
178.30 |
|
|
|
|
|
|
|
|
|
|
| 362 |
Lupin Research Inc., USA |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.00 |
223.20 |
|
|
|
|
|
|
|
|
|
|
| 363 |
Novel Laboratories, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
3,377.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 364 |
Novel Laboratories, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
31,061.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 365 |
Novel Laboratories, Inc., USA |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
6.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 366 |
Novel Laboratories, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
280.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 367 |
Novel Laboratories, Inc., USA |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
459.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 368 |
Novel Laboratories, Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
28.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 369 |
Novel Laboratories, Inc., USA |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
2.90 |
26.80 |
|
|
|
|
|
|
|
|
|
|
| 370 |
Novel Laboratories, Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
118.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 371 |
Novel Laboratories, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
3.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 372 |
Novel Laboratories, Inc., USA |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
0.00 |
280.70 |
|
|
|
|
|
|
|
|
|
|
| 373 |
Hormosan Pharma GmbH, Germany |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
545.00 |
1,088.50 |
|
|
|
|
Loan |
0.7500 |
2 yrs |
Unsecured |
Business Purpose |
|
| 374 |
Hormosan Pharma GmbH, Germany |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
1,089.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.7500 |
2 yrs |
Unsecured |
Business Purpose |
|
| 375 |
Hormosan Pharma GmbH, Germany |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
31.00 |
66.80 |
|
|
|
|
|
|
|
|
|
|
| 376 |
Hormosan Pharma GmbH, Germany |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
27.80 |
3.50 |
|
|
|
|
|
|
|
|
|
|
| 377 |
Hormosan Pharma GmbH, Germany |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
114.90 |
166.20 |
|
|
|
|
|
|
|
|
|
|
| 378 |
Hormosan Pharma GmbH, Germany |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
14.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 379 |
Hormosan Pharma GmbH, Germany |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
103.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 380 |
Hormosan Pharma GmbH, Germany |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
5.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 381 |
Nanomi B.V., Netherlands |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
0.00 |
173.70 |
|
|
|
|
|
|
|
|
|
|
| 382 |
Nanomi B.V., Netherlands |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
0.00 |
813.80 |
|
|
|
|
|
|
|
|
|
|
| 383 |
Nanomi B.V., Netherlands |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
359.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 384 |
Nanomi B.V., Netherlands |
|
Generic Health Pty Limited, Australia |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
11,886.70 |
11,886.70 |
|
|
|
|
|
|
|
|
|
|
| 385 |
Nanomi B.V., Netherlands |
|
Generic Health SDN. BHD., Malaysia |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
15.10 |
15.10 |
|
|
|
|
|
|
|
|
|
|
| 386 |
Nanomi B.V., Netherlands |
|
Hormosan Pharma GmbH, Germany |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
3,107.40 |
3,107.40 |
|
|
|
|
|
|
|
|
|
|
| 387 |
Nanomi B.V., Netherlands |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
6,72,687.60 |
6,72,687.60 |
|
|
|
|
|
|
|
|
|
|
| 388 |
Nanomi B.V., Netherlands |
|
Lupin Mexico S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
64.50 |
64.50 |
|
|
|
|
|
|
|
|
|
|
| 389 |
Nanomi B.V., Netherlands |
|
Lupin Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
598.90 |
598.90 |
|
|
|
|
|
|
|
|
|
|
| 390 |
Nanomi B.V., Netherlands |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
4,683.70 |
4,683.70 |
|
|
|
|
|
|
|
|
|
|
| 391 |
Nanomi B.V., Netherlands |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2,505.60 |
39,534.00 |
|
|
|
|
|
|
|
|
|
|
| 392 |
Nanomi B.V., Netherlands |
|
Multicare Pharmaceuticals Philippines, Inc., Philippines |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
37,028.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 393 |
Nanomi B.V., Netherlands |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
68,787.80 |
68,787.80 |
|
|
|
|
|
|
|
|
|
|
| 394 |
Nanomi B.V., Netherlands |
|
VISUfarma B.V., Netherlands |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
2,37,914.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 395 |
Nanomi B.V., Netherlands |
|
VISUfarma B.V., Netherlands |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
0.00 |
2,37,914.50 |
|
|
|
|
|
|
|
|
|
|
| 396 |
Nanomi B.V., Netherlands |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
7,190.10 |
7,666.20 |
|
|
|
|
Loan |
4.00 |
3 yrs |
Unsecured |
Business Purpose |
|
| 397 |
Nanomi B.V., Netherlands |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
212.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 398 |
Nanomi B.V., Netherlands |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
54.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 399 |
Lupin Atlantis Holdings SA, Switzerland |
|
Hormosan Pharma GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
1,958.60 |
1,013.40 |
|
|
|
|
|
|
|
|
|
|
| 400 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
335.20 |
40.00 |
|
|
|
|
|
|
|
|
|
|
| 401 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
2,555.50 |
1,557.90 |
|
|
|
|
|
|
|
|
|
|
| 402 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
146.10 |
282.50 |
|
|
|
|
|
|
|
|
|
|
| 403 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Manufacturing Solutions Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
143.80 |
406.40 |
|
|
|
|
|
|
|
|
|
|
| 404 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
18,709.60 |
14,318.80 |
|
|
|
|
|
|
|
|
|
|
| 405 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
762.00 |
820.10 |
|
|
|
|
|
|
|
|
|
|
| 406 |
Lupin Atlantis Holdings SA, Switzerland |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
2.20 |
24.00 |
|
|
|
|
|
|
|
|
|
|
| 407 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
0.00 |
67.10 |
|
|
|
|
|
|
|
|
|
|
| 408 |
Lupin Atlantis Holdings SA, Switzerland |
|
YL Biologics Ltd., Japan |
|
Jointly Controlled Entity |
Any other transaction |
Receivables |
|
- |
|
|
0.00 |
28.50 |
24.50 |
|
|
|
|
|
|
|
|
|
|
| 409 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
43.90 |
77.00 |
|
|
|
|
|
|
|
|
|
|
| 410 |
Lupin Atlantis Holdings SA, Switzerland |
|
Hormosan Pharma GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
23.20 |
69.60 |
|
|
|
|
|
|
|
|
|
|
| 411 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
279.30 |
44.30 |
|
|
|
|
|
|
|
|
|
|
| 412 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
117.30 |
102.60 |
|
|
|
|
|
|
|
|
|
|
| 413 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
184.50 |
143.80 |
|
|
|
|
|
|
|
|
|
|
| 414 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
90.80 |
201.50 |
|
|
|
|
|
|
|
|
|
|
| 415 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
246.30 |
259.50 |
|
|
|
|
|
|
|
|
|
|
| 416 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
492.70 |
630.00 |
|
|
|
|
|
|
|
|
|
|
| 417 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Payables |
|
- |
|
|
0.00 |
389.40 |
375.10 |
|
|
|
|
|
|
|
|
|
|
| 418 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
3,809.90 |
0.00 |
0.00 |
|
|
|
|
Loan |
5.00 |
9 yrs |
Unsecured |
Business Purpose |
|
| 419 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
7,608.20 |
0.00 |
0.00 |
|
|
|
|
Loan |
4.2500 |
9 yrs |
Unsecured |
Business Purpose |
|
| 420 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
61,495.50 |
61,495.50 |
|
|
|
|
|
|
|
|
|
|
| 421 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
1,726.20 |
1,726.20 |
|
|
|
|
|
|
|
|
|
|
| 422 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2,797.50 |
2,797.50 |
|
|
|
|
|
|
|
|
|
|
| 423 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
2,507.60 |
2,507.60 |
|
|
|
|
|
|
|
|
|
|
| 424 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
18,327.70 |
18,327.70 |
|
|
|
|
|
|
|
|
|
|
| 425 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Investment |
|
|
- |
|
|
0.00 |
41,702.50 |
41,702.50 |
|
|
|
|
|
|
|
|
|
|
| 426 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
139.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 427 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
556.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 428 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
772.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 429 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
459.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 430 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
632.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 431 |
Lupin Atlantis Holdings SA, Switzerland |
|
Hormosan Pharma GmbH, Germany |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1,504.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 432 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
6,470.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 433 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
1,450.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 434 |
Lupin Atlantis Holdings SA, Switzerland |
|
Hormosan Pharma GmbH, Germany |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
252.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 435 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
29.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 436 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
278.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 437 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
280.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 438 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
179.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 439 |
Lupin Atlantis Holdings SA, Switzerland |
|
Pharma Dynamics (Proprietary) Limited, South Africa |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
47.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 440 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
99.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 441 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
292.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 442 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
90.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 443 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
520.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 444 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
1,148.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 445 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Research Inc., USA |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
626.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 446 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Purchase of goods or services |
|
|
- |
|
|
0.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 447 |
Lupin Atlantis Holdings SA, Switzerland |
|
YL Biologics Ltd., Japan |
|
Jointly Controlled Entity |
Purchase of goods or services |
|
|
- |
|
|
6.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 448 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medisol S.A.S., France |
|
Fellow Subsidiary |
Dividend received |
|
|
- |
|
|
6,636.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 449 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
553.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 450 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Europe GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
152.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 451 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
1.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 452 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharma Canada Limited, Canada |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
5.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 453 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on our behalf reimbursed & Other Reimbursements |
|
- |
|
|
280.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 454 |
Lupin Life Sciences Limited, India |
|
LUPINLIFE Consumer Healthcare Limited, India |
|
Fellow Subsidiary |
Any other transaction |
Expenses incurred on their behalf recovered |
|
- |
|
|
0.00 |
0.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 455 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
3,485.30 |
7,355.80 |
|
|
|
|
Loan |
5.00 |
9 yrs |
Unsecured |
Business Purpose |
|
| 456 |
Lupin Atlantis Holdings SA, Switzerland |
|
Nanomi B.V., Netherlands |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
20,858.40 |
28,748.40 |
|
|
|
|
Loan |
3.7500 |
3 yrs |
Unsecured |
Business Purpose |
|
| 457 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Healthcare (UK) Limited, UK |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
27,534.50 |
27,996.30 |
|
|
|
|
Loan |
5.500 |
2 yrs |
Unsecured |
Business Purpose |
|
| 458 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
24,650.90 |
24,915.30 |
|
|
|
|
Loan |
4.500 |
3 yrs |
Unsecured |
Business Purpose |
|
| 459 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
18,962.20 |
19,165.60 |
|
|
|
|
Loan |
4.7500 |
3 yrs |
Unsecured |
Business Purpose |
|
| 460 |
VISUfarma B.V., Netherlands |
|
Iris Bidco SRL Italy |
|
Fellow Subsidiary |
Interest received |
|
|
- |
|
|
632.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 461 |
VISUfarma B.V., Netherlands |
|
VISUfarma S.p.A. Italy, Italy |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
323.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 462 |
VISUfarma B.V., Netherlands |
|
VISUfarma S.p.A. Italy, Italy |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
133.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 463 |
VISUfarma B.V., Netherlands |
|
VISUfarma UK Limited, UK |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
30.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 464 |
VISUfarma S.p.A. Italy, Italy |
|
VISUfarma B.V., Netherlands |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
2,313.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 465 |
Laboratorios Grin, S.A. de C.V., Mexico |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
56.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 466 |
Lupin Limited |
|
Lupin Manufacturing Solutions Limited, India |
|
Wholly -Owned Subsidiary |
Any other transaction |
Product Development Expense |
8,200.00 |
Approved |
|
|
3,194.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 467 |
VISUfarma B.V., Netherlands |
|
VISUfarma S.p.A. Italy, Italy |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 468 |
VISUfarma B.V., Netherlands |
|
Iris Bidco SAS,France |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 469 |
Nanomi B.V., Netherlands |
|
Hormosan Pharma GmbH, Germany |
|
Fellow Subsidiary |
Any other transaction |
Capital Contributions |
|
- |
|
|
0.00 |
0.00 |
5,497.90 |
|
|
|
|
|
|
|
|
|
|
| 470 |
Laboratorios Grin, S.A. de C.V., Mexico |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
3,194.70 |
0.00 |
38.40 |
|
|
|
|
|
|
|
|
|
|
| 471 |
VISUfarma B.V., Netherlands |
|
Iris Bidco SRL Italy |
|
Fellow Subsidiary |
Any other transaction |
Expns Payable |
|
- |
|
|
0.00 |
0.00 |
33.50 |
|
|
|
|
|
|
|
|
|
|
| 472 |
VISUfarma B.V., Netherlands |
|
Iris Bidco SRL Italy |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
24,261.50 |
|
|
|
|
|
|
|
|
|
|
| 473 |
VISUfarma B.V., Netherlands |
|
Iris Bidco SAS,France |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
16,318.90 |
|
|
|
|
|
|
|
|
|
|
| 474 |
VISUfarma B.V., Netherlands |
|
VISUfarma UK Limited, UK |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
169.30 |
|
|
|
|
|
|
|
|
|
|
| 475 |
VISUfarma B.V., Netherlands |
|
VISUfarma S.p.A. Italy, Italy |
|
Fellow Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
0.00 |
1,021.50 |
|
|
|
|
|
|
|
|
|
|
| 476 |
VISUfarma B.V., Netherlands |
|
VISUfarma S.p.A. Italy, Italy |
|
Fellow Subsidiary |
Any other transaction |
Expns Payable |
|
- |
|
|
0.00 |
0.00 |
179.60 |
|
|
|
|
|
|
|
|
|
|
| 477 |
VISUfarma B.V., Netherlands |
|
VISUfarma S.p.A. Italy, Italy |
|
Fellow Subsidiary |
Loan |
|
|
- |
|
|
0.00 |
0.00 |
130.60 |
|
|
|
|
|
|
|
|
|
|
| 478 |
VISUfarma S.p.A. Italy, Italy |
|
Iris Bidco SRL Italy |
|
Fellow Subsidiary |
Any other transaction |
Creditors |
|
- |
|
|
0.00 |
0.00 |
143.90 |
|
|
|
|
|
|
|
|
|
|
| 479 |
VISUfarma S.p.A. Italy, Italy |
|
Iris Bidco SRL Italy |
|
Fellow Subsidiary |
Any other transaction |
Debtors |
|
- |
|
|
0.00 |
0.00 |
599.40 |
|
|
|
|
|
|
|
|
|
|
| 480 |
Lupin Pharmaceuticals, Inc., USA |
|
Lupin Management, Inc., USA |
|
Fellow Subsidiary |
Sale of goods or services |
|
|
- |
|
|
77.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 481 |
Lupin Atlantis Holdings SA, Switzerland |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
0.00 |
80.10 |
|
|
|
|
|
|
|
|
|
|
| 482 |
Lupin Atlantis Holdings SA, Switzerland |
|
Lupin Pharmaceuticals, Inc., USA |
|
Fellow Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
0.00 |
548.70 |
|
|
|
|
|
|
|
|
|
|
| 483 |
Lupin Atlantis Holdings SA, Switzerland |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
0.00 |
286.50 |
|
|
|
|
|
|
|
|
|
|
| 484 |
Lupin Inc., USA |
|
Laboratorios Grin, S.A. de C.V., Mexico |
|
Fellow Subsidiary |
Any other transaction |
Trade Payables |
|
- |
|
|
0.00 |
23.90 |
42.70 |
|
|
|
|
|
|
|
|
|
|
| 485 |
Lupin Limited |
|
Lupin (Thailand) Limited, Thailand |
|
Wholly -Owned Subsidiary |
Any other transaction |
Application money paid towards securities |
|
- |
|
|
85.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 486 |
Lupin Inc., USA |
|
Generic Health Pty Limited, Australia |
|
Fellow Subsidiary |
Any other transaction |
Trade Receivables |
|
- |
|
|
0.00 |
0.00 |
149.90 |
|
|
|
|
|
|
|
|
|
|
| 487 |
Lupin Limited |
|
Nanomi B.V., Netherlands |
|
Wholly -Owned Subsidiary |
Any other transaction |
Application money paid towards securities |
|
- |
|
|
0.00 |
0.00 |
39,998.10 |
|
|
|
|
|
|
|
|
|
|
| 488 |
Nanomi B.V., Netherlands |
|
Medquimica Industria Farmaceutica LTDA, Brazil |
|
Fellow Subsidiary |
Any other transaction |
Income Receivable |
|
- |
|
|
0.00 |
0.00 |
107.80 |
|
|
|
|
|
|
|
|
|
|
|
Total value of transaction during the reporting period |
13,56,407.60 |
|
|